Table 1.
Comparison of the clinical characteristics, endocrinological variables of PCOS patients and controls
| Control (n = 10) | PCOS (n = 10) | P value | |
|---|---|---|---|
| Age (year) | 30.60 ± 1.06 | 30.40 ± 1.09 | NS |
| BMI (kg/m2) | 20.73 ± 0.95 | 20.84 ± 0.94 | NS |
| Basal serum LH (mIU/mL) | 5.40 ± 0.65 | 6.37 ± 1.14 | NS |
| Basal serum FSH (mIU/mL) | 7.56 ± 0.89 | 7.14 ± 0.59 | NS |
| Basal serum E2 (pmol/mL) | 451.99 ± 316.91 | 708.7 ± 363.77 | NS |
| Basal serum T (ng/ mL) | 0.54 ± 0.09 | 1.20 ± 0.13 | 0.001 |
| Basal serum P (nmol/L) | 0.63 ± 0.12 | 0.75 ± 0.12 | NS |
| Number of oocytes retrieved | 11.1 ± 1.36 | 19.2 ± 1.98 | 0.003 |
| MII oocytes (%) | 89.1 ± 1.99 | 72.4 ± 16.39 | 0.022 |
| Rate of fertilization (%) | 77.3 ± 3.92 | 69.9 ± 6.50 | NS |
| Top-quality embryo (%) | 63.5 ± 5.71 | 33.3 ± 2.88 | 0.001 |
| Rate of embryos develop to blastocyst (%) | 76.7 ± 8.51 | 23.1 ± 7.08 | 0.001 |
Abbreviations: BMI Body mass index, FF Follicular fluid, FSH Follicle stimulating hormone, LH Luteinizing hormone, E2 Estradiol, T Testosterone, PROG Progesterone, Ret. oocyte Number of oocytes retrieved, MII oocytes Number of metaphase II oocytes, NS Not significant. Data are expressed as mean ± SEM. Differences between groups were considered significant for p ≤ 0.05